1:13-cv-00370 - Novartis AG et al. v. Alvogen Pine Brook LLC et al.

Detail

Case Number

1:13-cv-00370

Current Status

closed

Cause of Action

Infringement

Related Case(s)

1:11-cv-01077

1:11-cv-01112

1:13-cv-00052

1:13-cv-00370

1:13-cv-00371

1:13-cv-00527

1:13-cv-01467

1:14-cv-00111

1:14-cv-00777

Court

Delaware District Court

Plaintiff(s)

Novartis AG

Lts Lohmann Therapie Systeme GMBH & Co KG

Novartis Pharma GMBH

Novartis International Pharmaceutical Ltd

Novartis Pharmaceuticals Corp

Operating Company

Defendant(s)

Alvogen Pine Brook LLC

Alvogen Group Inc

Judge

Richard G. Andrews

Filing Date

2013-03-07

Termination Date

2014-07-07

Not a member? Sign up for free!
Dockets
Text
CASE CLOSED per D.I. 180 in Lead Civil Action 13-52-RGA. (nms) (Entered: 07/08/2014)
CIVIL DOCKET
UPDATED CIVIL DOCKET
No Summons Issued (mdb) (Entered: 03/08/2013)
Summons Issued with Magistrate Consent Notice attached as to Alvogen Group Inc. on 3/8/2013; Alvogen Pine Brook Inc. on 3/8/2013. (mdb) (Entered: 03/08/2013)
COMPLAINT FOR PATENT INFRINGEMENT - filed against Alvogen Group Inc., Alvogen Pine Brook Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1244297.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(mdb) (Entered: 03/08/2013)
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mdb) (Entered: 03/08/2013)
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/23/13. Date of Expiration of Patents: 1/8/19. Thirty Month Stay Deadline: 7/23/2015. (mdb) (Entered: 03/08/2013)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,316,023; 6,335,031;. (mdb) (Entered: 03/08/2013)
Disclosure Statement pursuant to Rule 7.1 filed by LTS Lohmann Therapie-Systeme AG. (mdb) (Entered: 03/08/2013)
Disclosure Statement pursuant to Rule 7.1 filed by Novartis AG. (mdb) (Entered: 03/08/2013)
Disclosure Statement pursuant to Rule 7.1 filed by Novartis International Pharmaceutical Ltd. identifying Corporate Parent Novartis AG for Novartis International Pharmaceutical Ltd.. (mdb) (Entered: 03/08/2013)
Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (mdb) (Entered: 03/08/2013)
Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (mdb) (Entered: 03/08/2013)
MOTION for Pro Hac Vice Appearance of Attorney Christopher Loh, Attorney Nicholas Kallas and Attorney Filko Prugo - filed by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Pro Hac Vice Certification of Christopher Loh, # 2 Pro Hac Vice Certification of Nicholas Kallas, # 3 Pro Hac Vice Certification of Filko Prugo)(Silver, Daniel) (Entered: 03/14/2013)
[SEALED] ANSWER to 1 Complaint, and COUNTERCLAIM against All Plaintiffs by Alvogen Group Inc., Alvogen Pine Brook Inc.. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) Modified on 3/26/2013 (nms). (Entered: 03/26/2013)
MOTION for Pro Hac Vice Appearance of Attorney and Order for Chad A. Landmon, Josephine Liu and Saira B. Haider - filed by Alvogen Group Inc., Alvogen Pine Brook Inc.. (Attachments: # 1 Certification of Chad A. Landmon, # 2 Certification of Josephine Liu, # 3 Certification of Saira B. Haider)(Gattuso, Dominick) (Entered: 03/26/2013)
REDACTED VERSION of 13 Answer to Complaint, Counterclaim, by Alvogen Group Inc., Alvogen Pine Brook Inc.. (Attachments: # 1 Certificate of Service)(Gattuso, Dominick) Modified on 4/1/2013 (nms). (Entered: 03/28/2013)
SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. Alvogen Group Inc. served on 3/11/2013, answer due 4/1/2013. (Silver, Daniel) (Entered: 03/12/2013)
SUMMONS Returned Executed by Novartis Pharmaceuticals Corporation, Novartis AG, Novartis Pharma AG, Novartis International Pharmaceutical Ltd., LTS Lohmann Therapie-Systeme AG. Alvogen Pine Brook Inc. served on 3/11/2013, answer due 4/1/2013. (Silver, Daniel) (Entered: 03/12/2013)
Disclosure Statement pursuant to Rule 7.1 filed by Alvogen Pine Brook Inc.. (Gattuso, Dominick) (Entered: 03/26/2013)
Disclosure Statement pursuant to Rule 7.1 filed by Alvogen Group Inc.. (Gattuso, Dominick) (Entered: 03/26/2013)
Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 5/14/2013, at 1:30 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 4/16/2013. (nms) (Entered: 04/16/2013)
Reply to 13 Answer to Complaint, and Counterclaims, by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) Modified on 4/19/2013 (nms). (Entered: 04/19/2013)
STIPULATION and Proposed Order Consolidating C.A. No. 13-370-RGA with C.A. No. 13-52-RGA, by Alvogen Group Inc., Alvogen Pine Brook Inc., LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, (Entered: 05/10/2013)
[SEALED] Letter to The Honorable Richard G. Andrews from Daniel M. Silver, Esquire regarding Consolidation of C.A. No. 13-370-RGA with C.A. No. 13-52-RGA and Other Issues - re 20 Stipulation,. (Silver, Daniel) (Entered: 05/10/2013)
ORDER Granting (34 in 1:13-cv-00052-RGA, and 20 in 1:13-cv-00370-RGA) Stipulation and Order consolidating cases, filed by Novartis International Pharmaceutical Ltd., Alvogen Group Inc., LTS Lohmann Therapie-Systeme AG, Novartis Pharma AG, Novartis AG, Novartis Pharmaceuticals Corporation, Alvogen Pine Brook Inc.. Signed by Judge Richard G. Andrews on 5/13/2013. Associated Cases: 1:13-cv-00052-RGA, 1:13-cv-00370-RGA(nms) (Entered: 05/13/2013)
REDACTED VERSION of 21 Letter by LTS Lohmann Therapie-Systeme AG, Novartis AG, Novartis International Pharmaceutical Ltd., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 05/17/2013)
Timeline
filed_date
closed_date
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2014
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2015
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2016
Feb
Patents In Case

Not a member? Sign up for free!